ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Compounded Aseptic Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 29 Sept 2026, 22:07.

Opportunity overview

This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Baxter Healthcare Ltd

Matched by exact name
Contract value
£13.7m
Awarded
Not supplied
Contract signed
24 Feb 2025
Award ID
007093-2025-1
Status
active
Location
Newbury, Berkshire, UK, RG20 7QW, United Kingdom

Qualasept Limited t/a Bath ASU

Match pending…
Contract value
£1.6m
Awarded
Not supplied
Contract signed
24 Feb 2025
Award ID
007093-2025-2
Status
active
Location
Corsham, UK, SN13 9RG, United Kingdom

Baxter Healthcare Ltd

Matched by exact name
Contract value
£1.1m
Awarded
Not supplied
Contract signed
24 Feb 2025
Award ID
007093-2025-3
Status
active
Location
Newbury, Berkshire, UK, RG20 7QW, United Kingdom

Baxter Healthcare Ltd

Matched by exact name
Shared contract value
£5.1m
Awarded
Not supplied
Contract signed
24 Feb 2025
Suppliers
One of 3 awarded suppliers
Award ID
007093-2025-4
Status
active
Location
Newbury, Berkshire, UK, RG20 7QW, United Kingdom

ITH Pharma Limited

Matched by exact name
Shared contract value
£5.1m
Awarded
Not supplied
Contract signed
24 Feb 2025
Suppliers
One of 3 awarded suppliers
Award ID
007093-2025-4
Status
active
Location
London, UK, NW10 7NZ, United Kingdom

Qualasept Limited t/a Bath ASU

Match pending…
Shared contract value
£5.1m
Awarded
Not supplied
Contract signed
24 Feb 2025
Suppliers
One of 3 awarded suppliers
Award ID
007093-2025-4
Status
active
Location
Corsham, UK, SN13 9RG, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Compounded Aseptic MedicinesValue not stated
  • Compounded Aseptic MedicinesValue not stated
  • Compounded Aseptic MedicinesValue not stated
  • Compounded Aseptic Medicines - All Other PresentationsValue not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
NP38619
Status
complete
Review Details
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
limited
Main Procurement Category
goods
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015

Covered By

GPA

Legal basis

Id
32014L0024
Scheme
CELEX

Techniques

Has Framework Agreement
Yes

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Title
Compounded Aseptic Medicines
Has Options
No
Description
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra®), (Remicade®), (Remsima®) Nivolumab Pembrolizumab Pertuzumab The Authority intends to awarded all presentations within this Lot to a single supplier.
Entry 2
Id
2
Title
Compounded Aseptic Medicines
Has Options
No
Description
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera®), (Rixathon®), (Truxima®) The Authority intends to awarded all presentations within this Lot to a single supplier
Entry 3
Id
3
Title
Compounded Aseptic Medicines
Has Options
No
Description
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin®), (Herzuma®) Vincristine The Authority intends to awarded all presentations within this Lot to a single supplier.
Entry 4
Id
4
Title
Compounded Aseptic Medicines - All Other Presentations
Has Options
No
Description
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly®) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti®), (Ontruzant®) Trastuzumab Subcutaneous Vedolizumab Each product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework.

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 2
Id
2
Related Lot
2

Delivery Location

Description
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 3
Id
3
Related Lot
3

Delivery Location

Description
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 4
Id
4
Related Lot
4

Delivery Location

Description
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Telephone
+44 1312756000
Organisation 2
Id
GB-FTS-4552
Name
Baxter Healthcare Ltd

Roles

supplier

Address

Region
UK
Locality
Newbury, Berkshire
Postal Code
RG20 7QW
Country Name
United Kingdom
Street Address
Wallingford Road, Compton,

Details

Scale
large

Identifier

Legal Name
Baxter Healthcare Ltd

Contact

Telephone
+44 1635206000
Organisation 3
Id
GB-FTS-103751
Name
Qualasept Limited t/a Bath ASU

Roles

supplier

Address

Region
UK
Locality
Corsham
Postal Code
SN13 9RG
Country Name
United Kingdom
Street Address
Unit A15 Fiveways Light Industrial Estate, Westwells Road,

Details

Scale
large

Identifier

Legal Name
Qualasept Limited t/a Bath ASU
Organisation 4
Id
GB-FTS-33758
Name
ITH Pharma Limited

Roles

supplier

Address

Region
UK
Locality
London
Postal Code
NW10 7NZ
Country Name
United Kingdom
Street Address
Unit 4 Premier Park, Premier Park Road

Details

Scale
large

Identifier

Legal Name
ITH Pharma Limited

Contact

Fax Number
+44 2088388261
Telephone
+44 2088388260
Organisation 5
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525

Award information

Award 1
Id
007093-2025-1
Title
Compounded Aseptic Medicines
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4552
Name
Baxter Healthcare Ltd

Related lots

1
Award 2
Id
007093-2025-2
Title
Compounded Aseptic Medicines
Status
active

Suppliers

Supplier 1
Id
GB-FTS-103751
Name
Qualasept Limited t/a Bath ASU

Related lots

2
Award 3
Id
007093-2025-3
Title
Compounded Aseptic Medicines
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4552
Name
Baxter Healthcare Ltd

Related lots

3
Award 4
Id
007093-2025-4
Title
Compounded Aseptic Medicines - All Other Presentations
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4552
Name
Baxter Healthcare Ltd
Supplier 2
Id
GB-FTS-103751
Name
Qualasept Limited t/a Bath ASU
Supplier 3
Id
GB-FTS-33758
Name
ITH Pharma Limited

Related lots

4

Contracts and changes

Entry 1
Id
007093-2025-1
Title
Compounded Aseptic Medicines
Status
active
Award ID
007093-2025-1
Date Signed
24 Feb 2025, 00:00

Value

Amount
13,653,346
Currency
GBP
Entry 2
Id
007093-2025-2
Title
Compounded Aseptic Medicines
Status
active
Award ID
007093-2025-2
Date Signed
24 Feb 2025, 00:00

Value

Amount
1,565,729
Currency
GBP
Entry 3
Id
007093-2025-3
Title
Compounded Aseptic Medicines
Status
active
Award ID
007093-2025-3
Date Signed
24 Feb 2025, 00:00

Value

Amount
1,064,777
Currency
GBP
Entry 4
Id
007093-2025-4
Title
Compounded Aseptic Medicines - All Other Presentations
Status
active
Award ID
007093-2025-4
Date Signed
24 Feb 2025, 00:00

Value

Amount
5,085,024
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04e7a2-2025-02-24T16:38:51Zcompiled ·